Kira Scherer Wampler Sells 2,500 Shares of Doximity, Inc. (NASDAQ:DOCS) Stock

Doximity, Inc. (NASDAQ:DOCS) Director Kira Scherer Wampler sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, July 1st. The shares were sold at an average price of $28.00, for a total transaction of $70,000.00. Following the completion of the sale, the director now owns 10,258 shares in the company, valued at $287,224. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Kira Scherer Wampler also recently made the following trade(s):

• On Friday, May 17th, Kira Scherer Wampler sold 2,500 shares of Doximity stock. The shares were sold at an average price of $27.22, for a total value of $68,050.00.

Doximity Trading Down 2.2 %

DOCS stock opened at $26.38 on Thursday. The firm has a 50 day moving average of $26.80 and a 200-day moving average of $27.48. The firm has a market capitalization of $4.89 billion, a P/E ratio of 36.64, a price-to-earnings-growth ratio of 5.23 and a beta of 1.22. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $36.29.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings results on Thursday, May 16th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The firm had revenue of $118.06 million during the quarter, compared to the consensus estimate of $116.46 million. Doximity had a net margin of 31.04% and a return on equity of 17.44%. Sell-side analysts predict that Doximity, Inc. will post 0.74 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on DOCS. JPMorgan Chase & Co. upgraded shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price target on the stock in a report on Thursday, April 25th. William Blair reiterated an “outperform” rating on shares of Doximity in a research report on Friday, May 17th. Evercore ISI raised their price objective on Doximity from $28.00 to $29.00 and gave the stock an “in-line” rating in a research report on Friday, May 17th. Needham & Company LLC reiterated a “hold” rating on shares of Doximity in a report on Friday, May 17th. Finally, Morgan Stanley restated an “underweight” rating and set a $25.00 price target on shares of Doximity in a report on Tuesday, April 23rd. One investment analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $28.73.

Hedge Funds Weigh In On Doximity

A number of hedge funds and other institutional investors have recently modified their holdings of the company. LRI Investments LLC bought a new stake in shares of Doximity in the 1st quarter worth approximately $27,000. First Horizon Advisors Inc. raised its position in Doximity by 111.3% in the 4th quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock worth $28,000 after purchasing an additional 524 shares during the period. GAMMA Investing LLC bought a new stake in Doximity in the fourth quarter worth $40,000. DekaBank Deutsche Girozentrale purchased a new stake in Doximity during the first quarter valued at about $46,000. Finally, Essex Investment Management Co. LLC bought a new position in shares of Doximity during the first quarter valued at about $73,000. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.